METASTATIC PROSTATE ADENOCARCINOMA
Clinical trials for METASTATIC PROSTATE ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Prostate cancer drug study halted early – what researchers learned
Disease control TerminatedThis study tested the drug erdafitinib in 11 men with castration-resistant prostate cancer that had spread to bone. The goal was to see if the drug could slow the cancer and to study changes in blood and bone marrow. The study was stopped early, so results are limited.
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo therapy for advanced prostate cancer shows early promise
Disease control TerminatedThis early-phase study tested a new immunotherapy drug (vudalimab) alongside standard hormone therapy or chemotherapy in 4 men with prostate cancer that had spread. The goal was to see if the combination was safe and could shrink tumors or slow the disease. The trial was stopped …
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Radioactive treatment aims to ease bone pain in prostate cancer patients
Symptom relief TerminatedThis study tested a radioactive drug called Sn-117m-DTPA to see if it could reduce bone pain in men with prostate cancer that has spread to the bones. Only one person took part before the study was stopped early. The goal was to measure pain relief over several weeks.
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC